Optimizing criteria for N-terminal pro-B-type natriuretic peptide for eligibility and enrichment in trials in heart failure with preserved, mid-range and reduced ejection fraction

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure - Other Chronic Heart Failure, Other HFA Premium Access Heart Failure 2018

ESC 365 is supported by

ESC 365 is supported by